Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Abroad (travel likely)RecruitingPHASE2
Conditions
Down Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CU Anschutz, Children's Hospital Colorado, Aurora, Colorado, United States
Contact: Principal Investigator (Joaquin M Espinosa, PhD)Contact: Principal Investigator (Jessica L Bloom, MD)
Study leads
Joaquin Espinosa, PhD
Principal Investigator
Linda Crnic Institute for Down Syndrome, CU Anschutz